Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze

Journal of Neuroscience Methods

Volumn 169, Issue 1, 2008, Pages 109-118

  Albrechet Souza, Lucas ^a   Borelli, Karina G ^a   Brandão, Marcus L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elevated plus maze; Ethological categories; Factor analysis; Fos expression; Midazolam; One trial tolerance

Indexed keywords

MIDAZOLAM; PROTEIN FOS;

AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EXPLORATORY BEHAVIOR; FACTORIAL ANALYSIS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK ASSESSMENT;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; BRAIN MAPPING; COGNITION; DRUG TOLERANCE; FEAR; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; MAZE LEARNING; MIDAZOLAM; MOTOR ACTIVITY; NEUROPHARMACOLOGY; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR;

EID: 39749176350     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.11.025     Document Type: Article

References (55)

1. Albrechet-Souza L., Carvalho M.C., Franci C.R., and Brandão M.L. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm Behav 52 (2007) 267-273
2. Albrechet-Souza L., Oliveira A.R., De Luca M.C.Z., Tomazini F., Santos N.R., and Brandão M.L. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Prog Neuropsychopharmacol Biol Psychiatr 29 (2005) 571-579
3. Anseloni V.C.Z., and Brandão M.L. Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behav Pharmacol 8 (1997) 533-540
4. Anseloni V.C.Z., Motta V., Lima G., and Brandão M.L. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls. Braz J Med Biol Res 28 (1995) 597-601
5. Beckett S.R., Duxon M.S., Aspley S., and Marsden C.A. Central c-fos expression following 20 kHz/ultrasound induced defence behaviour in the rat. Brain Res Bull 42 (1997) 421-426
6. Bertoglio L.J., and Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Res 108 (2000) 197-203
7. Blanchard D.C., Blanchard R.J., and Rodgers R.J. Risk assessment and animal models of anxiety. In: Olivier B., Mos J., and Slangen J.L. (Eds). Animals models in psychopharmacology (1991), Birkhauser Verlag AG, Basel
8. Blanchard R.J., Yudko E.B., Rodgers R.J., and Blanchard D.C. Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav Brain Res 58 (1993) 155-165
9. Borelli K.G., Ferreira-Netto C., and Brandão M.L. Distribution of Fos immunoreactivity in the rat brain after freezing or escape elicited by inhibition of glutamic acid decarboxylase or antagonism of GABA-A receptors in the inferior colliculus. Behav Brain Res 170 (2006) 84-93
10. Borelli K.G., Ferreira-Netto C., Coimbra N.C., and Brandão M.L. Fos-like immunoreactivity in the brain associated with freezing or escape induced by inhibition of either glutamic acid decarboxylase or GABA-A receptors in the dorsal periaqueductal gray. Brain Res 105 (2005) 100-111
11. Brandão M.L., Anseloni V.C.Z., Pandóssio J.E., De Araújo J.E., and Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci Biobehav Rev 23 (1999) 863-875
12. Brandão M.L., Borelli K.G., Nobre M.J., Santos J.M., Albrechet-Souza L., Oliveira A.R., et al. Gabaergic regulation of the neural organization of fear in the midbrain tectum. Neurosci Biobehav Rev 29 (2005) 1299-1311
13. Canteras N.S., and Goto M. Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator. NeuroReport 10 (1999) 413-418
14. Carvalho M.C., Albrechet-Souza L., Masson S., and Brandão M.L. Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. Braz J Med Biol Res 38 (2005) 1857-1866
15. Cruz A.P.M., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the plus-maze. Pharmacol Biochem Behav 49 (1994) 171-176
16. Cruz-Morales S.E., Santos N.R., and Brandão M.L. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behav 72 (2002) 973-978
17. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20 (1995) 789-819
18. Dielenberg R.A., Hunt G.E., and McGregor I.S. "When a rat smells a cat": the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 104 (2001) 1085-1097
19. Fernandes C., and File S. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav 54 (1996) 31-40
20. Ferreira-Netto C., Borelli K.G., and Brandão M.L. Distinct Fos expression in the brain following freezing behavior elicited by stimulation with NMDA of the ventral or dorsal inferior colliculus. Exp Neurol 204 (2007) 693-704
21. Ferreira-Netto C., Borelli K.G., and Brandão M.L. Neural segregation of Fos-protein distribution in the brain following freezing and escape behaviors induced by injections of either glutamate or NMDA into the dorsal periaqueductal gray of rats. Brain Res 1031 (2005) 151-163
22. File S.E., Zangrossi H., Viana M., and Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacology 111 (1993) 491-494
23. File S.E., and Zangrossi H. One trial tolerance to the anxiolytic actions of benzodiazepine in the elevated plus-maze, or the development of a phobic state?. Psychopharmacology 110 (1993) 240-244
24. File S.E. One trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100 (1990) 281-282
25. Graeff F.G. Brain defense systems and anxiety. In: Roth M., Burrow G.D., and Noyes R. (Eds). Handbook of anxiety (1990), Elsevier Science Publishers, New York, NY, USA
26. Gray J.A., and McNaughton N. Fundamentals of the septo-hippocampal system. In: Gray J.A., and McNaughton N. (Eds). The neuropsychology of anxiety: an enquiry into the functions of septo-hippocampal system. 2nd ed. (2000), Oxford University Press, Oxford
27. Griebel G., Moreau J.L., Jenck F., Martin J.R., and Misslin R. Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav Proc 29 (1993) 37-48
28. Handley S.L., and McBlane J.W. 5-HT drugs in animal models of anxiety. Psychopharmacology 112 (1993) 13-20
29. Heidbreder C.A., and Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27 (2003) 555-579
30. Holmes A., and Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze as experience: further evidence for qualitative shift in emotional state. Pharmacol Biochem Behav 60 (1998) 473-488
31. Holschneider D.P., Yang J., Sadler T.R., Nguyen P.T., Givrad T.K., and Maarek J.-M.I. Mapping cerebral blood flow changes during auditory-cued conditioned fear in the nontethered, nonrestrained rat. Neuroimage 29 (2006) 1344-1358
32. Kalisch R., Salome N., Platzer S., Wigger A., Czisch M., Sommer W., et al. High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. Neuroimage 23 (2004) 382-391
33. Lamprea M.R., Cardenas F.P., Vianna D.M., Castilho V.M., Cruz-Morale S.E., and Brandão M.L. The distribution of fos immunoreactivity in rat brain following freezing and escape responses elicited by electrical stimulation of the inferior colliculus. Brain Res 950 (2002) 86-194
34. LeDoux J.E., Iwata J., Cichetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 8 (1988) 1529-2517
35. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 23 (2000) 155-184
36. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
37. Maren S. The threatened brain. Science 317 (2007) 1079-1083
38. Milad M.R., and Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420 (2002) 70-74
39. Mobbs D., Petrovic P., Marchant J.L., Hassabis D., Weiskopf N., Seymour B., et al. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 317 (2007) 1079-1083
40. Montgomery K.C. The relationship between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48 (1955) 254-260
41. Morgan M.A., and LeDoux J.E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 109 (1995) 681-688
42. Motta V., and Brandão M.L. Aversive and anti-aversive effects of morphine in the periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol Biochem Behav 44 (1993) 119-125
43. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 5th ed. (2005), Elsevier Academic Press, New York
44. Pellow S., Chopin P., File S.E., and Briley M. Validation of open-closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
45. Pereira J.K.D., Vieira R.J., Konishi C.T., Ribeiro R.A., and Frussa-Filho R. The phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65 (1999) 101-107
46. Pezze M.A., Bast T., and Feldon J. Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cereb Cortex 13 (2003) 371-380
47. Rodgers R.J., and Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper S.J., and Hendrie C.A. (Eds). Ethology and psychopharmacology (1994), John Wiley & Sons, Chichester
48. Rodgers R.J., and Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52 (1995) 297-303
49. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behaviour and responses to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113 (1993) 237-242
50. Silveira M.C., Sandner G., and Graeff F.G. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze. Behav Brain Res 56 (1993) 115-118
51. Silveira M.C., Zangrossi H., Viana M., Silveira R., and Graeff F.G. Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze. Behav Brain Res 126 (2001) 13-21
52. Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 31 (2007) 18-40
53. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
54. Vianna D.M.L., Borelli K.G., Ferreira-Netto C., and Brandão M.L. Fos-like immunoreactive neurons following electrical stimulation of the dorsal periaqueductal gray at freezing and escape thresholds. Brain Res Bull 62 (2003) 179-189
55. Vouimba R.M., Garcia R., Baudry M., and Thompson R.F. Potentiation of conditioned freezing following dorsomedial prefrontal cortex lesions does not interfere with fear reduction in mice. Behav Neurosci 114 (2000) 720-724